Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Retinol

EU orphan designation number: EU/3/14/1307   
Active ingredient: Retinol
Indication: Prevention of bronchopulmonary dysplasia
Sponsor: orphanix GmbH
Peter Roseggerstrasse 41, A-4910 Ried im Innkreis, Österreich

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
26/08/2014 Orphan designation EMA/OD/018/14 (2014)6113 of 22/08/2014
12/06/2017 Transfer of orphan designation EMA/OD/018/14/T/01 (2017)4089 of 08/06/2017